← FDA DRUG APPROVALS

FDA ANDA · ANDA089042

PROCAINAMIDE HYDROCHLORIDE

Sponsor: WATSON LABS

APPLICATION
ANDA089042
TYPE
ANDA
ORIGINAL APPROVAL
1985-10-22
LATEST ACTION
1991-12-16
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

PROCAINAMIDE HYDROCHLORIDEDiscontinued
PROCAINAMIDE HYDROCHLORIDE 750MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

1991-12-16Labeling · Supplement 5AP
1991-08-30Labeling · Supplement 4AP
1991-08-07Manufacturing (CMC) · Supplement 2AP
1989-01-12Labeling · Supplement 1AP
1985-10-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →